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Research brief

FINDINGS
FROM LANDSCAPE
ANALYSIS IN KOGI ON
PRE-ECLAMPSIA/ECLAMPSIA
Despite global efforts to reduce preventable
maternal and neonatal mortality, Nigeria’s
maternal mortality ratio is estimated at 576
deaths per 100,000 live births and neonatal
death is estimated at 37 per 1,000 live
births 1.
Maternal and newborn deaths due to pre-eclampsia and
eclampsia (PE/E) are preventable, yet in Nigeria this is the most
significant direct cause of maternal deaths.
To appreciate the enormity of this problem at country and state
levels, a landscape analysis was conducted by the Population
Council in 2015 on PE/E in seven states in Nigeria. The main
objectives of the landscape analysis were:
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•

To understand the level of programmatic and policy
support for PE/E prevention and treatment;

•

To analyze the gaps in providers’ knowledge and
competence in preventing, detecting, and managing PE/E;

•

To determine primary health care (PHC) facilities’
capacities to manage PE/E;

•

To assess community awareness, beliefs, and experiences
around PE/E;

•

To understand the volume of research on PE/E in the last
15 years; and

•

To determine priority areas for research and programmatic
interventions around PE/E.

The Ending Eclampsia project seeks to expand access
to proven, underutilized interventions and commodities
for the prevention, early detection, and treatment of preeclampsia and eclampsia and strengthen global partnerships.

Made possible by the generous support of the
American people through the United States Agency for
International Development (USAID).

PE/E IN BRIEF
• Pre-eclampsia is a condition
in pregnant women marked by an
increase in blood pressure and
protein in urine after 20 weeks
gestation.
• Providing high quality antenatal care
improves the prevention and early
detection of pre-eclampsia and can
prevent its progression to eclampsia.
• Eclampsia is a life-threatening
condition characterized by
convulsions in women with PE.
• Women in developing countries are
300 times more likely to die from
eclampsia than women in developed
countries.
• Prescribing low-dose aspirin and
calcium to at-risk women can prevent
pre-eclampsia and eclampsia.
• Pre-eclampsia and eclampsia can
be managed by administering antihypertensive drugs and magnesium
sulphate (MgSO4).
• MgSO4 is the safest and most
effective treatment for severe PE/E,
and is one of 13 UN Life-Saving
Commodities for Women and
Children.
• PE/E and other hypertensive
disorders in pregnancy increase the
risk of pre-term births, which can
lead to low birth weight, anemia, and
stunting.
• Improved prevention, increased
detection, and effective treatment
of PE/E can prevent unnecessary
maternal and newborn deaths.

The Population Council conducts research and delivers
solutions that improve lives around the world. Big
ideas supported by evidence: It’s our model for global
change. popcouncil.org
© 2015 The Population Council, Inc.

FACILITY CAPACITY AND
PREPAREDNESS
To assess institutional preparedness, researchers
visited eight facilities in Kogi State and recorded that
only one (13%) of the facilities had guidelines available
for management of pre-eclampsia, one (13%) had
all ANC equipment for the detection of PE/E and two
(25%) use MgSO4 for the treatment of eclampsia.
During these facility assessments, researchers
determined whether the facilities had the key ANC
equipment required to detect pre-eclampsia, manage
severe PE/E, and monitor for MgSO4 toxicity (figure 1).

FIGURE 1 Proportion of facilities with key
equipment to detect PE and manage severe PE/E

“You see, the problem here is that
all these policies are available
at the national level; but the
implementers don’t have or see the
copies.”
—POLICYMAKER, KOGI

PROVIDER KNOWLEDGE AND
SKILLS
Providers had good knowledge on signs and symptoms
of PE (96%) and E (91%), but only 43.2% could correctly
identify signs and symptoms of chronic hypertension
and 14% could identify severe PE correctly.
Researchers also assessed health providers’
knowledge of drugs used for preventing and managing
PE/E as well as calcium gluconate to treat MgSO4
toxicity (figure 2).

FIGURE 2 Provider knowledge of drugs for PE/E
prevention and management (n=44)

Contrary to the facility assessment, four (50%) facility
managers reported always using MgSO4 to treat PE/E,
two (25%) said it is sometimes used, and two (25%)
reported that it is never used. When asked how they
obtain MgSO4, 33% of managers said they receive
it routinely from central supply, half ask clients to
purchase it and 17% said they procure it elsewhere
(such as NGOs).
Although hospitals have the capacity to provide signal
functions for emergency obstetric and neonatal care
(EmONC), Table 1 shows that PHCs have limited
capacity for conducting even basic EmONC.
TABLE 1 Signal functions for emergency obstetric
and newborn care (EmONC)
Figure 2 shows limited provider knowledge on
prophylactic use of calcium and aspirin for women
at risk of PE and which anti-hypertensives (aldomet
or nifedipine) to use for managing high BP during
pregnancy. The Pritchard regimen for MgSO4
administration is considered the ‘gold standard’ for
preventing and treating convulsions in severe PE/E,
but few providers (16%) could accurately describe the
appropriate doses of MgSO4 or name the antidote for
MgSO4 toxicity, calcium gluconate (7%).
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QUALITY OF CARE
Quality of care was assessed through observations of 15
client-provider interactions and 15 client exit interviews
with the same pregnant women. Researchers assessed
eight essential components of quality antenatal care
(ANC). Figure 3 describes the components that clients
received.

FIGURE 3 Percent of clients who received all
eight ANC components

In addition to the eight essential components of ANC,
questions and tests should be conducted to assess a
woman’s risk of developing PE/E, to detect PE/E, and
inform clients of the signs of impending eclampsia.
During 75% of the observed ANC consultations,
providers performed the necessary checks to detect
women at risk of developing PE. These included history
of high blood pressure (BP) and diabetes, date of last
delivery, client’s parity, age and weight, edema of
face, hands, legs, and ankles. In addition, all providers
observed in Kogi measured women’s BP and checked
urine for protein.
None of the providers, however, advised the clients
on the symptoms of impending eclampsia (severe
headache, blurred vision, and pre-eclampsia with
generalized body swelling).

COMMUNITY KNOWLEDGE
AND PERCEPTIONS
The study also included in-depth interviews (IDIs) and
focus group discussions (FGDs) with PE/E survivors,
community stakeholders, and families affected by
PE/E.
Married men reported witchcraft, economic problems,
fear, death of a loved one, and ‘over thinking’ as
causes of high blood pressure, swelling, and bleeding

in pregnancy. The men also said: to prevent these
complications, they should encourage their wives to
register early in their pregnancies for ANC, help them
with house chores, give them support so they don’t
‘over think,’ and make them happy all the time.
Women stated that high blood pressure during
pregnancy is caused by witchcraft and over thinking,
adding that it can lead to sleepless nights. One woman
said that exposure to too much noise can cause
high blood pressure. Women also discussed seeking
traditional or spiritual help for high blood pressure from
herbalists and Imams.

“If you have hypertension,
the herbalist will tell you
to do some things, but where
there is no money to do it,
the high BP will continue.
If you go to pray, prayer can help
a little, but it can’t finish
the high BP. High BP
is the worst sickness in our town.”
—FEMALE FGD PARTICIPANT, KOGI
Overall, the qualitative findings show that the signs and
symptoms associated with PE/E are often attributed
to other causes and community members often
seek traditional or spiritual healing before medical
care. Misconceptions, myths, and mistrust between
communities and health providers negatively influence
care-seeking behaviors.

SURVIVORS’ EXPERIENCES
Interviews with survivors documented their careseeking pathways, including their PE/E experience,
availability and accessibility of essential services and
commodities, and the outcomes of the pregnancy
for mother and child. Survivors’ experiences provide
insight informing strategies to work more closely with
communities and health facilities improve access to,
and use of, quality care.
The women interviewed were similar in age, ages at
marriage and first pregnancy, and education. The
following quotation demonstrates lack of awareness
and poor health seeking behavior in a young woman
during her first pregnancy.
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“I am 17 years old, and I
was married two years ago.
This is my first pregnancy.
I never attended ANC before,
but I came to the hospital when
I had a severe headache for
over two weeks, I became dizzy
and fell down. I went to a hospital.
I didn’t know what happened,
but later the doctor told me
that my BP was 250/150.
I am OK now, but lost my baby.”
—PE/E SURVIVOR, KOGI

for MgSO4 toxicity and its antidote, calcium gluconate.
There is also limited capacity for newborn resuscitation.
The final, essential component to reduce mortality from
PE/E is community awareness. Community members
need to know the signs of PE/E and understand the
danger it poses for mothers and babies so they can
seek medical care promptly.
A multi-pronged approach is required to address
the systems issues that create barriers to women’s
access to health care during pregnancy. Detecting and
managing PE/E early can improve the survival rate in
women and babies in Nigeria.

RECOMMENDATIONS
•

Advocacy for streamlining state procurement and
link to a national or central distribution system;

•

Connecting with United Nations Commission on
Life-Saving Commodities (UNCoLSC) for Women
and Children, especially for maternal drugs which
include MgSO4;

•

Training on quality ANC: what, why, how, when and
where;

•

Introduce task-shifting policy focusing on MNH
“policy implementation plan” to include antihypertensives and MgSO4;

•

Train PHC workers to detect and provide loading
dose of MgSO4;

•

Community awareness campaigns on the
importance of ANC and seeking care early; and

•

Engage men to encourage their support of their
wives.

DISCUSSION & CONCLUSION
This landscape analysis identified the gaps in facilities’
and providers’ capacities for preventing, detecting, and
managing PE/E; it assessed community awareness,
beliefs, and experiences of PE/E; and it determined the
gaps and priority areas for research and programs to
improve access to prevention and treatment.
It is clear, at the state policy level, that there is limited
knowledge of what has been developed nationally;
there is confusion about how policies, guidelines, and
protocols reach not only the states but also the facilities
themselves, where they don’t seem to exist at all.
For effective PE/E management, health facilities
need to stock necessary drugs and ANC equipment,
and institutionalize guidelines for PE/E treatment.
Researchers noted irregular supply of basic drugs,
equipment, and supplies, particularly MgSO4, patella
hammers and the MgSO4 antidote, calcium gluconate,
which no facilities stocked.
Providers’ knowledge is generally poor in Kogi; health
care providers need to be trained and re-trained on PE
prevention—including when to administer prophylactic
drugs such as calcium supplements and aspirin—and
its early detection, and how and when to administer
anti-hypertensives and MgSO4 for early treatment of
the condition.
In addition to ensuring providers are adequately trained
to administer MgSO4 at the right time, and with the
proper doses, they also need to know the warning signs
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